NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 919 filers reported holding NOVARTIS A G in Q4 2015. The put-call ratio across all filers is 1.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $4,401,000 | +7.4% | 51,093 | +14.8% | 0.02% | +4.5% |
Q3 2015 | $4,096,000 | -0.6% | 44,498 | +6.3% | 0.02% | +10.0% |
Q2 2015 | $4,121,000 | +56.6% | 41,880 | +57.0% | 0.02% | +66.7% |
Q1 2015 | $2,632,000 | +6.5% | 26,680 | 0.0% | 0.01% | +33.3% |
Q4 2014 | $2,472,000 | -27.0% | 26,680 | -25.9% | 0.01% | -35.7% |
Q3 2014 | $3,387,000 | – | 36,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |